Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Brendan McAtamney |
|
|
Reason for the notification |
a) |
Position/status |
PDMR - Chief Executive - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
108,684 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2025 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Nigel Clerkin |
|
|
Reason for the notification |
a) |
Position/status |
PDMR -Chief Financial Officer - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
77,866 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2025 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Greg Flynn |
|
|
Reason for the notification |
a) |
Position/status |
PDMR - Global Head of Ashfield Commercial & Medical Services - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
29,029 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2023 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Colin Stanley |
|
|
Reason for the notification |
a) |
Position/status |
PDMR -President of Ashfield Advisory - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
63,025 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2023 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Eimear Kenny |
|
|
Reason for the notification |
a) |
Position/status |
PDMR - Group Head of Human Resources - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
26,702 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2023 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Liam Logue |
|
|
Reason for the notification |
a) |
Position/status |
PDMR - Head of Corporate Development - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
33,557 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2023 to 4 DECEMBER 2026 |
Notification of Transactions by Persons Discharging Managerial Responsibilities and Persons Closely Associated with them
[This form is required for disclosure of transactions under Article 19 of Regulation (EU) No 596/2014 of the European Parliament and of the Council of 16 April 2014 on market abuse (Market Abuse Regulation)]
1 |
Details of the person discharging managerial responsibilities/person closely associated |
a) |
Name |
Damien Moynagh |
|
|
Reason for the notification |
a) |
Position/status |
PDMR - General Counsel & Company Secretary - UDG Healthcare plc |
b) |
Initial Notification Amendment |
Initial Notification |
3 |
Details of the issuer, emission allowance market participant, auction platform, auctioneer or auction monitor |
a) |
Name |
UDG Healthcare plc |
b) |
LEI |
549300IWG5ZPP6B8HH13 |
4 |
Details of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted |
a) |
Description of the financial instrument, type of instrument Identification code |
Ordinary Shares of €0.05 each in UDG Healthcare plc ISIN: IE0033024807 |
b) |
Nature of the transaction |
Grant of nominal cost options under the 2019 Performance Share Plan |
c) |
Price(s) and volume(s) |
Price(s) |
Volume(s) |
€0.05 |
28,886 |
|
d) |
Aggregated information - Aggregated volume - Price |
|
e) |
Date of the transaction |
04/12/2019 |
f) |
Place of the transaction |
London Stock Exchange, Main Market |
g) |
Additional Information |
Period during which options can be exercised 4 JANUARY 2023 to 4 DECEMBER 2026 |
For further information, please contact:
Damien Moynagh
General Counsel & Company Secretary
Tel: +353-1-4689000